NRAS and melanoma: Another study revealed that combined inhibition of MEK and mitotic regulator Polo-like kinase 1 (Plk1) resulted in significant growth reduction of NRAS-mutant melanoma cells in vitro and also regression of xenografted NRAS-mutant melanoma in vivo [117].